Cargando…
Pharmacosimulation of delays and interruptions during administration of tirofiban: a systematic comparison between EU and US dosage regimens
Tirofiban is a glycoproteine (GP) IIb/IIIa receptor antagonist, which inhibits platelet-platelet aggregation and is a potential adjunctive antithrombotic treatment in patients with acute coronary syndromes (ACS) or high-risk percutaneous coronary interventions (PCI). It is administered intravenously...
Autores principales: | Heramvand, Nadia, Masyuk, Maryna, Muessig, Johanna M., Nia, Amir M., Karathanos, Athanasios, Polzin, Amin, Valgimigli, Marco, Gurbel, Paul A., Tantry, Udaya S., Kelm, Malte, Jung, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363357/ https://www.ncbi.nlm.nih.gov/pubmed/35482154 http://dx.doi.org/10.1007/s11239-022-02654-0 |
Ejemplares similares
-
Are we ever too old?: Characteristics and outcome of octogenarians admitted to a medical intensive care unit
por: Muessig, Johanna Maria, et al.
Publicado: (2017) -
Comprehensive Analysis of Macrocirculation and Microcirculation in Microgravity During Parabolic Flights
por: Bimpong-Buta, Nana-Yaw, et al.
Publicado: (2020) -
In Vitro Evidence for the Role of Cytokine Storm in the Generation of Stent Thrombosis in COVID-19 Patients
por: Gurbel, Paul A., et al.
Publicado: (2022) -
Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance
por: Wernly, Bernhard, et al.
Publicado: (2017) -
Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis?
por: Wernly, Bernhard, et al.
Publicado: (2016)